Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

Clinical trial NCT01677182 · TERMINATED

Trial details

NCT number: NCT01677182
Sponsor: Takeda
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Bipolar Disorder

Start date: 2012-08-01
Primary completion: 2014-08-01
Enrollment: 535

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.